Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 233

1.

Incidence, risk factors and mortality of tuberculosis in Danish HIV patients 1995-2007.

Taarnhøj GA, Engsig FN, Ravn P, Johansen IS, Larsen CS, Røge B, Andersen AB, Obel N.

BMC Pulm Med. 2011 May 23;11:26. doi: 10.1186/1471-2466-11-26.

2.

Incidence of tuberculosis after HAART initiation in a cohort of HIV-positive patients in Burkina Faso.

Dembélé M, Saleri N, Carvalho AC, Saouadogo T, Hien AD, Zabsonre I, Koala ST, Simporé J, Matteelli A.

Int J Tuberc Lung Dis. 2010 Mar;14(3):318-23.

PMID:
20132623
3.

Incidence of tuberculosis and early mortality in a large cohort of HIV infected patients receiving antiretroviral therapy in a tertiary hospital in Addis Ababa, Ethiopia.

Kassa A, Teka A, Shewaamare A, Jerene D.

Trans R Soc Trop Med Hyg. 2012 Jun;106(6):363-70. doi: 10.1016/j.trstmh.2012.03.002. Epub 2012 Apr 20.

PMID:
22521216
4.

Incidence of tuberculosis in HIV-infected patients receiving HAART: interaction between TST and CD4 count.

Martín-Echevarria E, Rodríguez-Zapata M, Torralba M, Fernández JM, Moreno A, Casado JL, Dronda F, Pérez-Elías MJ, Navas E, Moreno S.

Int J Tuberc Lung Dis. 2011 Oct;15(10):1347-52. doi: 10.5588/ijtld.10.0686.

PMID:
22283893
5.

HAART and risk of tuberculosis in HIV-infected South African children: a multi-site retrospective cohort.

Martinson NA, Moultrie H, van Niekerk R, Barry G, Coovadia A, Cotton M, Violari A, Gray GE, Chaisson RE, McIntyre JA, Meyers T.

Int J Tuberc Lung Dis. 2009 Jul;13(7):862-7.

PMID:
19555536
6.

Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan.

Seyler C, Toure S, Messou E, Bonard D, Gabillard D, Anglaret X.

Am J Respir Crit Care Med. 2005 Jul 1;172(1):123-7. Epub 2005 Apr 1.

PMID:
15805184
7.
8.

Incidence of Tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America.

Girardi E, Sabin CA, d'Arminio Monforte A, Hogg B, Phillips AN, Gill MJ, Dabis F, Reiss P, Kirk O, Bernasconi E, Grabar S, Justice A, Staszewski S, Fätkenheuer G, Sterne JA; Antiretroviral Therapy Cohort Collaboration.

Clin Infect Dis. 2005 Dec 15;41(12):1772-82. Epub 2005 Nov 11.

PMID:
16288403
9.

Improved outcomes of HIV-1-infected adults with tuberculosis in the era of highly active antiretroviral therapy.

Hung CC, Chen MY, Hsiao CF, Hsieh SM, Sheng WH, Chang SC.

AIDS. 2003 Dec 5;17(18):2615-22.

PMID:
14685055
10.

Response to HAART in treatment-naive HIV-infected patients with a prior diagnosis of tuberculosis or other opportunistic infections.

Dronda F, Sobrino P, Hernández-Novoa B, Caro-Murillo AM, Montero M, Iribarren JA, Sanz J, Del Mar Alonso M, Labarga P, Bernal E, Moreno S; CoRIS.

Curr HIV Res. 2011 Jun;9(4):229-36. doi: 10.2174/157016211796320324.

PMID:
21631429
11.

Risk factors for opportunistic illnesses in children with human immunodeficiency virus in the era of highly active antiretroviral therapy.

Ylitalo N, Brogly S, Hughes MD, Nachman S, Dankner W, Van Dyke R, Seage GR 3rd; Pediatric AIDS Clincial Trials Group Protocol 219C Team.

Arch Pediatr Adolesc Med. 2006 Aug;160(8):778-87.

PMID:
16894075
12.

Hospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: a Danish population-based, nationwide cohort study.

Sogaard OS, Lohse N, Gerstoft J, Kronborg G, Ostergaard L, Pedersen C, Pedersen G, Sørensen HT, Obel N.

Clin Infect Dis. 2008 Nov 15;47(10):1345-53. doi: 10.1086/592692.

PMID:
18834317
13.

Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study.

Engsig FN, Hansen AB, Omland LH, Kronborg G, Gerstoft J, Laursen AL, Pedersen C, Mogensen CB, Nielsen L, Obel N.

J Infect Dis. 2009 Jan 1;199(1):77-83. doi: 10.1086/595299.

PMID:
19007313
14.

Incidence and associated factors of pulmonary tuberculosis in HIV-infected children after highly active antiretroviral therapy (HAART) in China: a retrospective study.

Mu W, Zhao Y, Sun X, Ma Y, Yu L, Liu X, Zhao D, Dou Z, Fang H, Zhang F.

AIDS Care. 2014;26(9):1127-35. doi: 10.1080/09540121.2014.882492. Epub 2014 Feb 10.

PMID:
24512621
15.

Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.

Salzberger B, Hartmann P, Hanses F, Uyanik B, Cornely OA, Wöhrmann A, Fätkenheuer G.

Infection. 2005 Oct;33(5-6):345-9.

PMID:
16258865
16.

Risk factors for mortality among HIV-positive patients with and without active tuberculosis in Dar es Salaam, Tanzania.

Mugusi SF, Ngaimisi E, Janabi MY, Mugusi FM, Minzi OM, Sasi PG, Bakari M, Lindquist L, Aklillu E, Sandstrom EG.

Antivir Ther. 2012;17(2):265-74. doi: 10.3851/IMP1956. Epub 2011 Nov 17.

PMID:
22293579
17.

Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda.

Moore D, Liechty C, Ekwaru P, Were W, Mwima G, Solberg P, Rutherford G, Mermin J.

AIDS. 2007 Mar 30;21(6):713-9.

PMID:
17413692
18.

Risk factors for default from tuberculosis treatment in HIV-infected individuals in the state of Pernambuco, Brazil: a prospective cohort study.

Maruza M, Albuquerque MF, Coimbra I, Moura LV, Montarroyos UR, Miranda Filho DB, Lacerda HR, Rodrigues LC, Ximenes RA.

BMC Infect Dis. 2011 Dec 16;11:351. doi: 10.1186/1471-2334-11-351.

19.

Post-HAART tuberculosis in adults and adolescents with HIV in India: incidence, clinical and immunological profile.

Rajasekaran S, Raja K, Jeyaseelan L, Vijilat S, Priya K, Mohan K, Parvez A, Mahilmaran A, Chandrasekar C.

Indian J Tuberc. 2009 Apr;56(2):69-76.

PMID:
19810588
20.

Incidence and risk factors for tuberculosis in HIV-infected patients while on antiretroviral treatment in Cambodia.

Choun K, Thai S, Pe R, Lorent N, Lynen L, van Griensven J.

Trans R Soc Trop Med Hyg. 2013 Apr;107(4):235-42. doi: 10.1093/trstmh/trt001. Epub 2013 Jan 16.

PMID:
23324313

Supplemental Content

Support Center